Related by context. Frequent words. (Click for all words.) 68 myocardial infarction stroke 64 cardiovascular morbidity 64 Pioglitazone 64 thrombotic events 64 tumor lysis syndrome 62 cerebrovascular events 61 QT prolongation 61 cardiovascular hospitalization 61 acute coronary 61 thromboembolic events 61 myocardial infarctions 61 thiazolidinedione 60 fatal myocardial infarction 60 glitazones 60 discontinuations due 60 angiotensin receptor blockers 60 rosiglitazone 60 thromboembolism 60 hypoglycemic events 59 stroke myocardial infarction 59 irbesartan 59 hyperglycaemia 59 pioglitazone 59 hypercalcemia 59 rosuvastatin 59 neuropsychiatric symptoms 59 antihypertensive agents 58 renal dysfunction 58 Secondary endpoints include 58 serum calcium 58 valsartan 58 myocardial infarction MI 58 cardiovascular mortality 58 coronary revascularization 58 CYP#C# [001] 58 active comparator 58 antithrombotic 58 tolvaptan 58 lipid lowering drugs 58 muraglitazar 58 calcineurin inhibitors 58 Natalizumab 58 composite endpoint 58 mycophenolate mofetil 58 fasting glucose levels 58 insulin glargine 58 acute coronary syndromes ACS 57 atherothrombosis 57 ramipril 57 de ath 57 vasomotor symptoms 57 INTEGRILIN 57 glargine 57 elevated triglycerides 57 Asentar 57 rofecoxib 57 metabolic acidosis 57 lipid profiles 57 TRILIPIX 57 pertuzumab 57 6R BH4 57 orthostatic hypotension 57 LDL lowering 57 treatment emergent adverse 57 HbA1C 57 elevated CRP 57 angiotensin converting enzyme inhibitors 57 Lp PLA2 57 verapamil 57 coronary heart 57 J Am Coll 57 PROCRIT 57 antihypertensive drugs 56 unfractionated heparin 56 serum cholesterol 56 serum uric acid 56 platelet inhibition 56 selective COX 2 56 thiazolidinediones 56 hypercholesterolemia 56 Secondary endpoints included 56 hyperkalemia 56 systemic embolism 56 morbidity mortality 56 hepatotoxicity 56 renal insufficiency 56 fondaparinux 56 tipranavir 56 elotuzumab 56 surrogate endpoint 56 cardiac toxicity 56 ischemic cardiomyopathy 56 hyperphosphatemia 56 antihypertensive medications 56 hydroxychloroquine 56 genetic polymorphisms 56 colorectal adenomas 56 PREZISTA r 56 selegiline 56 tanespimycin 56 fibrate